Get the Stockscreener App
0.00
100.00%
-7.04
180 Life Sciences Corp stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
See More
Previous Close:
$7.04
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$1.08B
Revenue:
-
Net Income/Loss:
$-3.12M
P/E Ratio:
0.00
EPS:
-4.8149
Net Cash Flow:
$-2.69M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$17.75
180 Life Sciences Corp Stock (ATNF) Company Profile
Name
180 Life Sciences Corp
Sector
Industry
Phone
650-507-0669
Address
3000 EL CAMINO REAL, PALO ALTO
Compare ATNF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATNF
180 Life Sciences Corp
|
0.00 | 1.08B | 0 | -3.12M | -2.69M | -4.8149 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-21 | Initiated | Maxim Group | Buy |
180 Life Sciences Corp Stock (ATNF) Latest News
Real time scanner hits for 180 Life Sciences Corp. Equity Warrant explainedEntry Point & Risk Managed Investment Signals - Newser
Will 180 Life Sciences Corp. price bounce be sustainableJobs Report & AI Driven Stock Reports - Newser
What technical models suggest about 180 Life Sciences Corp. Equity Warrant’s comebackJuly 2025 EndofMonth & Capital Protection Trading Alerts - Newser
Will 180 Life Sciences Corp. see short term momentum2025 Trading Volume Trends & Safe Entry Zone Identification - Newser
Predicting 180 Life Sciences Corp. Equity Warrant trend using moving averagesMarket Activity Recap & Free Community Consensus Stock Picks - Newser
Candlestick signals on 180 Life Sciences Corp. stock todayJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - Newser
Is this a good reentry point in 180 Life Sciences Corp. Equity WarrantTrade Exit Summary & Weekly High Potential Stock Alerts - Newser
Multi asset correlation models including 180 Life Sciences Corp.Weekly Trade Report & Precise Swing Trade Entry Alerts - Newser
How moving averages guide 180 Life Sciences Corp. Equity Warrant tradingMarket Movement Recap & AI Driven Stock Price Forecasts - Newser
180 Life Sciences Corp. Equity Warrant stock trend forecastMarket Performance Report & Reliable Entry Point Alerts - Newser
Risk vs reward if holding onto 180 Life Sciences Corp. Equity WarrantJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - Newser
Is 180 Life Sciences Corp. Equity Warrant stock poised for growth2025 Historical Comparison & Free Growth Oriented Trading Recommendations - Newser
Can 180 Life Sciences Corp. Equity Warrant hit a new high this monthBuy Signal & High Conviction Buy Zone Alerts - Newser
Published on: 2025-08-27 15:30:16 - Newser
180 Life Sciences Corp. Equity Warrant stock volume spike explainedBear Alert & Safe Entry Point Identification - Newser
Technical analysis overview for 180 Life Sciences Corp. stockGDP Growth & Reliable Momentum Entry Alerts - Newser
Volatility clustering patterns for 180 Life Sciences Corp.Long Setup & Technical Entry and Exit Alerts - Newser
Published on: 2025-08-27 15:45:43 - Newser
Will 180 Life Sciences Corp. outperform the marketTrade Exit Report & Advanced Swing Trade Entry Plans - Newser
VGASW stock prediction for this weekQuarterly Earnings Summary & Reliable Price Breakout Signals - Newser
180 Life Sciences Corp. stock daily chart insightsEarnings Risk Summary & AI Forecast for Swing Trade Picks - Newser
Understanding 180 Life Sciences Corp. Equity Warrant’s price movementGDP Growth & Safe Entry Trade Reports - Newser
Analyzing recovery setups for 180 Life Sciences Corp. Equity Warrant investorsTrade Analysis Summary & Comprehensive Market Scan Insights - Newser
How hedge fund analytics apply to 180 Life Sciences Corp. Equity Warrant stockEarnings Risk Report & AI Enhanced Trading Alerts - Newser
How is 180 Life Sciences Corp. managing supply chain issues getLinesFromResByArray error: size == 0 - 더경남뉴스
Visual analytics tools that track 180 Life Sciences Corp. Equity Warrant performanceJuly 2025 Retail & Real-Time Chart Pattern Alerts - Newser
How institutional ownership impacts 180 Life Sciences Corp. Equity Warrant stockMarket Performance Report & Daily Risk Controlled Trade Plans - Newser
Applying chart zones and confluence areas to 180 Life Sciences Corp.Weekly Trade Report & AI Enhanced Trade Execution Alerts - Newser
180 Life Sciences Corp. stock trendline breakdownCPI Data & Accurate Entry and Exit Point Alerts - Newser
Institutional scanner results for 180 Life Sciences Corp.Inflation Watch & Verified Technical Signals - Newser
180 Life Sciences Corp. Equity Warrant stock trendline breakdownTrade Risk Assessment & Daily Volume Surge Trade Alerts - Newser
180 Life Sciences Corp. stock trend forecast2025 Short Interest & Reliable Price Action Trade Plans - Newser
What indicators show strength in 180 Life Sciences Corp.Market Rally & Weekly High Return Opportunities - Newser
Signal strength of 180 Life Sciences Corp. Equity Warrant stock in tech scannersFed Meeting & Risk Managed Investment Strategies - Newser
How to recover losses in 180 Life Sciences Corp. stock2025 Earnings Impact & Fast Gaining Stock Reports - Newser
Real time breakdown of 180 Life Sciences Corp. stock performanceShort Setup & Advanced Technical Analysis Signals - Newser
Order flow analysis tools used on 180 Life Sciences Corp.2025 Dividend Review & Verified Entry Point Detection - Newser
Real time social sentiment graph for 180 Life Sciences Corp.July 2025 Review & Daily Chart Pattern Signals - Newser
Applying sector rotation models to 180 Life Sciences Corp. Equity WarrantMarket Risk Summary & Safe Capital Growth Stock Tips - Newser
New Ether Treasury ETHZilla Stock Turns Lower After $250M Buyback - Investopedia
Applying chart zones and confluence areas to 180 Life Sciences Corp. Equity Warrant - Newser
Using Python tools to backtest 180 Life Sciences Corp. strategies2025 Trading Recap & Risk Controlled Swing Alerts - Newser
What candlestick patterns are forming on 180 Life Sciences Corp.July 2025 Chart Watch & Weekly Watchlist for Hot Stocks - Newser
Is it time to cut losses on 180 Life Sciences Corp. Equity WarrantWeekly Trend Recap & AI Powered Trade Plan Recommendations - Newser
180 Life Sciences Corp. Stock Poised for Technical ComebackMarket Activity Summary & Safe Entry Point Alerts - Newser
180 Life Sciences Corp Stock (ATNF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):